BRIEF-GSK sees headline results of SUMMIT trial with Breo around Sept/Oct

July 29 (Reuters) - GlaxoSmithKline Plc CEO Andrew Witty told analysts: * CEO says headline results of SUMMIT trial with Breo likely around Sept/Oct * CEO says big-to-big pharma deals have high "pain" threshold and risky; GSK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.